IE68417B1 - Enantiomers of 2-tetrahydrofuran derivatives intermediates therefor and their preparation - Google Patents

Enantiomers of 2-tetrahydrofuran derivatives intermediates therefor and their preparation

Info

Publication number
IE68417B1
IE68417B1 IE208191A IE208191A IE68417B1 IE 68417 B1 IE68417 B1 IE 68417B1 IE 208191 A IE208191 A IE 208191A IE 208191 A IE208191 A IE 208191A IE 68417 B1 IE68417 B1 IE 68417B1
Authority
IE
Ireland
Prior art keywords
compound
formula
enantiomer
vith
tetrahydrofuran
Prior art date
Application number
IE208191A
Other languages
English (en)
Other versions
IE912081A1 (en
Inventor
Heinrich Estermann
William Joseph Houlihan
Prasad Koteswara Kapa
Russell Lee Underwood
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE912081A1 publication Critical patent/IE912081A1/en
Publication of IE68417B1 publication Critical patent/IE68417B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IE208191A 1990-06-19 1991-06-18 Enantiomers of 2-tetrahydrofuran derivatives intermediates therefor and their preparation IE68417B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54043890A 1990-06-19 1990-06-19
US64739691A 1991-01-29 1991-01-29

Publications (2)

Publication Number Publication Date
IE912081A1 IE912081A1 (en) 1992-01-01
IE68417B1 true IE68417B1 (en) 1996-06-12

Family

ID=27066435

Family Applications (1)

Application Number Title Priority Date Filing Date
IE208191A IE68417B1 (en) 1990-06-19 1991-06-18 Enantiomers of 2-tetrahydrofuran derivatives intermediates therefor and their preparation

Country Status (21)

Country Link
EP (1) EP0462935B1 (enExample)
JP (1) JP2709330B2 (enExample)
KR (1) KR920000772A (enExample)
AT (1) ATE125261T1 (enExample)
AU (2) AU649681B2 (enExample)
CA (1) CA2044786A1 (enExample)
CS (1) CS185191A3 (enExample)
DE (1) DE69111311T2 (enExample)
DK (1) DK0462935T3 (enExample)
ES (1) ES2076502T3 (enExample)
FI (1) FI912964L (enExample)
GR (1) GR3017437T3 (enExample)
HK (1) HK111996A (enExample)
HU (1) HU210548B (enExample)
IE (1) IE68417B1 (enExample)
IL (1) IL98524A (enExample)
MY (1) MY107022A (enExample)
NZ (1) NZ238573A (enExample)
PL (1) PL164981B1 (enExample)
PT (1) PT97994B (enExample)
TW (1) TW255897B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208352A (en) * 1992-04-02 1993-05-04 Sandoz Ltd. Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compounds
DE69903381T2 (de) * 1998-07-17 2003-06-18 Fuji Photo Film Co Ltd Photozelle und photoelektrochemische Zelle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178261A3 (en) * 1984-10-10 1986-12-30 Sandoz Ag Substituted 2-furanyl or 5-oxo-2-furanyl-alkoxy phosphoryl alkyl cyclimmonium salts
US4601987A (en) * 1985-02-27 1986-07-22 Massachusetts Institute Of Technology Enzymatic production of optical isomers of 2-halopropionic acids
DE3666435D1 (en) * 1985-08-30 1989-11-23 Sandoz Ag Substituted hydroxy-heterocyclyl-alkoxy phosphinyloxy trialkylaminium hydroxide inner salt oxides, processes for their preparation and their use as pharmaceuticals
US4673672A (en) 1985-10-28 1987-06-16 Sandoz Pharmaceuticals Corp. Substituted-[hydroxy(tetrahydro)-5-oxo-(2- and 3-furanyl or 2-thienyl)alkoxyphosphinyloxy]-alkanaminium hydroxide, inner salt oxides
US4868319A (en) * 1987-12-22 1989-09-19 Sandoz Pharm. Corp. Process for the preparation of monoalkylcarbamate group-containing compounds

Also Published As

Publication number Publication date
CA2044786A1 (en) 1991-12-20
AU649681B2 (en) 1994-06-02
KR920000772A (ko) 1992-01-29
DE69111311D1 (de) 1995-08-24
PL290719A1 (en) 1992-07-27
MY107022A (en) 1995-08-30
FI912964A0 (fi) 1991-06-18
IL98524A (en) 1995-12-31
EP0462935B1 (en) 1995-07-19
AU677403B2 (en) 1997-04-24
AU7843991A (en) 1992-01-02
NZ238573A (en) 1993-11-25
DK0462935T3 (da) 1995-11-06
IL98524A0 (en) 1992-07-15
JPH04270276A (ja) 1992-09-25
PT97994B (pt) 1998-11-30
PL164981B1 (pl) 1994-10-31
PT97994A (pt) 1992-03-31
GR3017437T3 (en) 1995-12-31
AU7140794A (en) 1994-11-03
HUT58340A (en) 1992-02-28
HU911882D0 (en) 1991-12-30
ES2076502T3 (es) 1995-11-01
JP2709330B2 (ja) 1998-02-04
FI912964A7 (fi) 1991-12-20
IE912081A1 (en) 1992-01-01
CS185191A3 (en) 1992-01-15
HU210548B (en) 1995-05-29
TW255897B (enExample) 1995-09-01
ATE125261T1 (de) 1995-08-15
HK111996A (en) 1996-07-05
DE69111311T2 (de) 1996-03-14
EP0462935A1 (en) 1991-12-27
FI912964L (fi) 1991-12-20

Similar Documents

Publication Publication Date Title
CH683996A5 (fr) Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
IE49301B1 (en) A phenylalkylaminoethylsalicylamide,its preparation and pharmaceutical compositions containing it
FR2755135A1 (fr) Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
EP0261017B1 (fr) Esters d'aminoacides d'alcools cycloaliphatiques, procédé de préparation et utilisation comme médicaments
EP0632026B1 (fr) Nouveaux dérivés d'alpha amino acides leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JPH05239075A (ja) 含リンイソプレノイド誘導体
US4598084A (en) Optically active derivatives of N-arylated oxazolidine-2-one, the process for preparing same and their application in therapeutics
EP0462935B1 (en) Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation
EP0007441B1 (en) N - (n-acetyl-l-methionyl) - 3,4 -diethoxy-carbonyloxy-phenethylamine, process for preparing same and a pharmaceutical composition containing said compound.
MC1845A1 (fr) Derives de pyrimidine
JP2003529585A (ja) ケモカインレセプターアンタゴニスト
EP0402033B1 (en) Carboxamide derivatives
US5229377A (en) Process for the preparation of the (R) stereoisomer of the monobutyric ester of 2,2-bis(hydroxymethyl)-tetrahydrofuran, its use in preparing stereoisomers of pharmacologically active compounds, and certain specific stereoisomers produced thereby
US5338730A (en) Use of the (R) isomer of 2-[(2-octa-decyloxymethyl-tetrahydro-2-furanylmethoxy)-hydroxyphosphinyloxy]-N,N,N-trimethylethanaminium hydroxide inner salt-4-oxide in treating multiple sclerosis
EP0008259A1 (fr) Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP1073664B1 (fr) Derives d'(alpha-aminophosphino) peptides et compositions les contenant
US4749696A (en) Hydroxy-[1-substituted carbonyl-2-(or 3-) piperidinyl methoxy]phosphinyloxy]-N,N,N-trialkylalkaneaminium hydroxide inner salt oxides having antitumor activity
FR2701261A1 (fr) Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US5276180A (en) Process for making succinyl acetone
CN1050845C (zh) 一种Leustroducsin化合物及其在药物制备中的应用及含该化合物的药物组合物
BE881210A (fr) Composition pharmaceutique pour le traitement de l'hypertrophie prostatique benigne et methode d'utilisation de celle-ci
LU82694A1 (fr) Nouveaux composes de purine,leur procede de production et composition pharmaceutique les contenant
FR2614303A1 (fr) Derives de nitrosourees, leur nouveau procede de preparation et leurs applications therapeutiques.
HK1007857B (en) New compound, leustroducsin h, its preparation and its therapeutic use
FR2467846A1 (fr) Nouveaux b hydroxy esters de piperidyle

Legal Events

Date Code Title Description
MM4A Patent lapsed